A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec
Clinical trial NCT00250042 · COMPLETED
Trial details
- NCT number
- NCT00250042
- Sponsor
- New Mexico Cancer Research Alliance
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2005-04-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.